Sabre 2400 Electrosurgery Generator, 220V, 50Hz
Navigation Links
Sabre 2400 Electrosurgery Generator, 220V, 50Hz
| Products | Sabre 2400 Electrosurgery Generator, 220V, 50Hz |
| Company | CONMED Corporation |
| Item | Sabre 2400 Electrosurgery Generator, 220V, 50Hz |
| Features | Thermal damage free cutting, 9000 volts peak to peak in the coagulation mode and 300 watts, auto spray, enhanced bipolar mode. |
| Description | The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator. |
| Info | CONMED Corporation Customer Service: (315) 797-8375 Web site: http://www.conmed.com/ |
Related medicine products :
1. Sabre 2400
2. Sabre 180
3. Sabre 2400, 110V, 60Hz
4. Sabre 2400, 100V, 50Hz/60Hz
5. Sabre 2400, 220V, 50Hz
6. Sabre 2400, 240V, 50Hz
7. Sabre 180, 110V, 60Hz
8. Sabre 180, 230V, 50Hz
9. Sabre 180, 100V, 50Hz/60Hz
10. Sabre 2400 Electrosurgery Generator, 110V, 60Hz
11. Sabre 2400 Electrosurgery Generator, 100V, 50Hz/60Hz
Breaking Medicine News(10 mins):Health News:Planview and Carestream Health Discuss the Intelligent Portfolio on December 17 Webinar 2Health News:Planview and Carestream Health Discuss the Intelligent Portfolio on December 17 Webinar 3Health News:FEHBP Open Enrollment Period to be Discussed on Special Rebroadcast of 'Inside Government' 2Health News:Pelosi: Lifting the Ban on Federal Funding for Syringe Exchange is a Victory for Science and for Public Health 2Health News:Most Hospital Patients Don't Know What Meds They're Taking 2Health News:Most Hospital Patients Don't Know What Meds They're Taking 3
[0] Planview and Carestream Health Discuss the Intelligent Portfolio on December 17 Webinar [0] FEHBP Open Enrollment Period to be Discussed on Special Rebroadcast of 'Inside Government'[0] Pelosi: Lifting the Ban on Federal Funding for Syringe Exchange is a Victory for Science and for Public Health[0] Savient To Present at the 28th Annual JP Morgan Healthcare Conference[0] Most Hospital Patients Don't Know What Meds They're Taking
Other Medicine News:Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 2Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 3Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 4Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 5Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 6Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 7Health News:Psoriasis Drug Raptiva Pulled From U.S. Market 2Health News:Psoriasis Drug Raptiva Pulled From U.S. Market 3Health News:Acid Reducers May Not Help All With Asthma 2Health News:Acid Reducers May Not Help All With Asthma 3
FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug ApplicationsPsoriasis Drug Raptiva Pulled From U.S. MarketUnited States District Court Issues Temporary Restraining Order Against NUHW and Former Leaders of SEIU UHW; Court Orders Information and Property Belonging to SEIU UHW Members to Be ReturnedAUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in AdolescentsAmerican College of Pediatricians: Another Blow to Children's RightsAcid Reducers May Not Help All With Asthma
Breaking Medicine Technology:Federal Judge Rejects GlaxoSmithKline's Claims of Privilege 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4Dynatronics Receives 180-Day NASDAQ Extension 2Genomas Presents Drug Specific Genetic Determinants of Statin Safety and Efficacy at the XV International Symposium on Atherosclerosis 48894 1Genomas Presents Drug Specific Genetic Determinants of Statin Safety and Efficacy at the XV International Symposium on Atherosclerosis 48894 2Cleveland Residents Lining up to Help Save a Life with Free Donor Kits 48893 1Cleveland Residents Lining up to Help Save a Life with Free Donor Kits 48893 2Boston Scientifics Urology Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 48889 1Boston Scientifics Urology Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 48889 2Boston Scientifics Urology Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 48889 3Boston Scientifics Urology Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 48889 4Boston Scientifics Urology Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 48889 5Boston Scientifics Urology Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 48889 6
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |